Assignee
ALLERGAN PHARMACEUTICALS INT LTD
IE·22 granted patents·47 pending applications·59 citations·filing 2013–2025
Top patents by PatentIndex Score
69 records- 0196US11857542B2Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2023·Granted Jan 2, 2024·11 cites·4 claims
- 0296US11717515B2Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2021·Granted Aug 8, 2023·13 cites·4 claims
- 0395US12194030B2Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Granted Jan 14, 2025·5 cites·7 claims
- 0495US12090148B2Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2021·Granted Sep 17, 2024·9 cites·10 claims
- 0595US12070450B2Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2023·Granted Aug 27, 2024·9 cites·4 claims
- 0694US12329750B2Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Granted Jun 17, 2025·2 cites·4 claims
- 0792US12350259B2Methods of treating migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2022·Granted Jul 8, 2025·1 cites·7 claims
- 0890US2026083710A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2025·Application pending·0 cites
- 0988US12465598B2Methods of treating migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Granted Nov 11, 2025·0 cites·5 claims
- 1088US2025064788A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 1188US2026014127A1Methods of treating migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2025·Application pending·0 cites
- 1284US2025171522A1Regeneration of damaged tissueALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 1382US2024100221A1Preparation and/or formulation of proteins cross-linked with polysaccharidesALLERGAN PHARMACEUTICALS INT LTD·Filed 2023·Application pending·0 cites
- 1481US2024252597A1Formation of boneALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 1581US2024000898A1In vivo synthesis of elastic fiberALLERGAN PHARMACEUTICALS INT LTD·Filed 2023·Application pending·0 cites
- 1678US2023263862A1Formation of boneALLERGAN PHARMACEUTICALS INT LTD·Filed 2023·Application pending·0 cites
- 1777US2023121324A1In vivo synthesis of elastic fiberALLERGAN PHARMACEUTICALS INT LTD·Filed 2022·Application pending·0 cites
- 1876US9908682B2Storage of ampoules containing pharmaceutical formulations using a sealed container comprising an oxygen scavengerALLERGAN PHARMACEUTICALS INT LTD·Filed 2014·Granted Mar 6, 2018·7 cites·7 claims
- 1975US2025186412A1Methods of treating migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2025·Application pending·0 cites
- 2075US2025186413A1Methods of treating migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2025·Application pending·0 cites
- 2173US2025325638A1Vivo synthesis of elastic fiberALLERGAN PHARMACEUTICALS INT LTD·Filed 2025·Application pending·0 cites
- 2273US2025325012A1Composition containing digestive enzymes and nutrients suitable for enteral administrationALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 2372US2023338481A1Digestive enzyme composition suitable for enteral administrationALLERGAN PHARMACEUTICALS INT LTD·Filed 2023·Application pending·0 cites
- 2471US12383545B1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2025·Granted Aug 12, 2025·0 cites·18 claims
- 2571US2022008612A1Preparation and/or formulation of proteins cross-linked with polysaccharidesALLERGAN PHARMACEUTICALS INT LTD·Filed 2021·Application pending·0 cites
- 2671US2025186422A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 2770US2023158128A1Cgrp antagonists and clostridial derivatives for the treatment of neuropsychiatric and neurological disordersALLERGAN PHARMACEUTICALS INT LTD·Filed 2022·Application pending·0 cites
- 2869US11065365B2Preparation and/or formulation of proteins cross-linked with polysaccharidesALLERGAN PHARMACEUTICALS INT LTD·Filed 2020·Granted Jul 20, 2021·0 cites·25 claims
- 2969US2025327059A1High potency pancreatin pharmaceutical compositionsALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 3069US2023105611A1Combination therapy with cgrp antagonists and clostridial derivativesALLERGAN PHARMACEUTICALS INT LTD·Filed 2022·Application pending·0 cites
- 3168US11077226B2Scalable three-dimensional elastic construct manufacturingALLERGAN PHARMACEUTICALS INT LTD·Filed 2020·Granted Aug 3, 2021·0 cites·18 claims
- 3268US10688057B25-aminosalicylic acid capsule formulationALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Granted Jun 23, 2020·1 cites·18 claims
- 3367US2025325532A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2025·Application pending·0 cites
- 3467US2021353825A1Scalable three-dimensional elastic construct manufacturingALLERGAN PHARMACEUTICALS INT LTD·Filed 2021·Application pending·0 cites
- 3566US10653814B2Preparation and/or formulation of proteins cross-linked with polysaccharidesALLERGAN PHARMACEUTICALS INT LTD·Filed 2016·Granted May 19, 2020·0 cites·24 claims
- 3666US10206882B2Stable digestive enzyme compositionsALLERGAN PHARMACEUTICALS INT LTD·Filed 2013·Granted Feb 19, 2019·0 cites·13 claims
- 3766US2021038700A1Formation of boneALLERGAN PHARMACEUTICALS INT LTD·Filed 2020·Application pending·0 cites
- 3865US2024180883A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 3965US2024122843A1Methods of scar prevention and/or treatmentALLERGAN PHARMACEUTICALS INT LTD·Filed 2023·Application pending·0 cites
- 4064US10736942B2Formation of boneALLERGAN PHARMACEUTICALS INT LTD·Filed 2016·Granted Aug 11, 2020·0 cites·13 claims
- 4164US9820946B2Pharmaceutical soft gelatin capsule dosage form with modified guar gumALLERGAN PHARMACEUTICALS INT LTD·Filed 2014·Granted Nov 21, 2017·0 cites·17 claims
- 4263US10993996B2Digestive enzyme composition suitable for enteral administrationALLERGAN PHARMACEUTICALS INT LTD·Filed 2014·Granted May 4, 2021·1 cites·18 claims
- 4363US10842913B2Scalable three-dimensional elastic construct manufacturingALLERGAN PHARMACEUTICALS INT LTD·Filed 2013·Granted Nov 24, 2020·0 cites·38 claims
- 4463US9795569B2Pharmaceutical soft gelatin capsule dosage form with modified guar gumALLERGAN PHARMACEUTICALS INT LTD·Filed 2014·Granted Oct 24, 2017·0 cites·20 claims
- 4563US2020222315A1Formulations and methods for vaginal delivery of antiprogestinsALLERGAN PHARMACEUTICALS INT LTD·Filed 2020·Application pending·0 cites
- 4663US2021379029A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2021·Application pending·0 cites
- 4762US2019328845A1In vivo synthesis of elastic fiberALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Application pending·0 cites
- 4861US10744096B2Pharmaceutical soft gelatin capsule dosage form with modified guar gumALLERGAN PHARMACEUTICALS INT LTD·Filed 2017·Granted Aug 18, 2020·0 cites·17 claims
- 4961US2021283229A1Digestive enzyme composition suitable for enteral administrationALLERGAN PHARMACEUTICALS INT LTD·Filed 2021·Application pending·0 cites
- 5061US2020030415A1Combination therapy with cgrp antagonists and clostridial derivativesALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ALLERGAN PHARMACEUTICALS INT LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →